Send to

Choose Destination
See comment in PubMed Commons below
Med Decis Making. 2006 Mar-Apr;26(2):182-93.

The cost-effectiveness of strategies to reduce mortality from an intentional release of aerosolized anthrax spores.

Author information

  • 1Section of General Internal Medicine, Yale University School of Medicine, 950 Campbell Avenue, West Haven, CT 06516, USA.



Intentional exposures to aerosolized Bacillus anthracis spores have caused fatalities.


To evaluate the cost-effectiveness of strategies to reduce mortality from future inhalational anthrax exposures.


Computer cohort simulation of a 100,000-person single-site exposure (worst-case scenario) and a 100-person multiple-site exposure (resembling the recent US attack). For each scenario, universal vaccination and an emergency surveillance and response (ESR) system were compared with a default strategy that assumed eventual discovery of the exposure.


If an exposure was unlikely to occur or was small in scale, neither vaccination nor an ESR system was cost-effective. If an exposure was certain and large in scale, an ESR system was more cost-effective than vaccination ($73 v. $29,600 per life-year saved), and a rapid response saved more lives than improved surveillance.


Strategies to reduce deaths from anthrax attacks are cost-effective only if large exposures are certain. A faster response is more beneficial than enhanced surveillance.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk